Literature DB >> 7459150

Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies.

.   

Abstract

Entities:  

Mesh：

Year:  1980        PMID： 7459150      PMCID： PMC482464          DOI： 10.1136/hrt.44.6.672

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  105 in total

Review 1.  Molecular genetics of cardiomyopathies.

Authors:  G Shah; R Roberts
Journal:  J Nucl Cardiol       Date:  2000 Mar-Apr       Impact factor: 5.952

2.  The anesthetic management for emergency operation on a patient with dilated cardiomyopathy.

Authors:  Y Fujita; Y Hirabayashi; S Yokosuka; K Miyashita; R Shimizu
Journal:  J Anesth       Date:  1990-07       Impact factor: 2.078

3.  Abstention from alcohol in dilated cardiomyopathy: complete regression of the clinical disease but persistence of myocardial perfusion defects on exercise thallium-201 tomography.

Authors:  Y Juillière; C Gillet; N Danchin; A Thouvenin; G Karcher; F Paille; A Bertrand; D Barrucand; F Cherrier
Journal:  Eur J Nucl Med       Date:  1990

Review 4.  Gene expression in spermiogenesis.

Authors:  H Tanaka; T Baba
Journal:  Cell Mol Life Sci       Date:  2005-02       Impact factor: 9.261

Review 5.  The MOGE(S) classification for cardiomyopathies: current status and future outlook.

Authors:  Julian G Westphal; Angelos G Rigopoulos; Constantinos Bakogiannis; Sarah E Ludwig; Sophie Mavrogeni; Boris Bigalke; Torsten Doenst; Matthias Pauschinger; Carsten Tschöpe; P Christian Schulze; Michel Noutsias
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

6.  Impairments of myocardial sympathetic activity may reflect the progression of myocardial damage or dysfunction in hypertrophic cardiomyopathy.

Authors:  Shinro Matsuo; Yasuyuki Nakamura; Takayoshi Tsutamoto; Masahiko Kinoshita
Journal:  J Nucl Cardiol       Date:  2002 Jul-Aug       Impact factor: 5.952

7.  Characterization of cardiomyopathy cases at a forensic institute in the period 1992-2006 and perspectives for screening.

Authors:  Shoaib Afzal; Ingrid Bayer Kristensen
Journal:  Forensic Sci Med Pathol       Date:  2008-01-30       Impact factor: 2.007

Review 8.  Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

9.  Anaesthetic induction in a child with end-stage cardiomyopathy.

Authors:  W S Schechter; C Kim; M Martinez; B F Gleason; D P Lund; F A Burrows
Journal:  Can J Anaesth       Date:  1995-05       Impact factor: 5.063

10.  HLA-DRB1 gene polymorphism in patients with dilated cardiomyopathy.

Authors:  Q Wang; Y Liao; F Gong; H Mao; J Zhang
Journal:  J Tongji Med Univ       Date:  2000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.